|
Delayed
Bombay S.E.
18:02:28 07/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 32.00 INR | -4.90% |
|
-4.90% | -23.99% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 |
|---|---|---|
| Market Cap 1 | 91.84 | 79.88 |
| Change | - | -13.02% |
| Enterprise Value (EV) 1 | 61.1 | 64.14 |
| Change | - | 4.98% |
| P/E | 21.2x | 19.1x |
| PBR | 1.04x | 0.86x |
| PEG | -1.1x | -5.48x |
| Capitalization / Revenue | 1.12x | 0.84x |
| EV / Revenue | 0.74x | 0.68x |
| EV / EBITDA | 7.34x | 6.31x |
| EV / EBIT | 16x | 12.6x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 1.896 | 1.83 |
| Distribution rate | - | - |
| Net sales 1 | 82.35 | 94.91 |
| EBITDA 1 | 8.319 | 10.16 |
| EBIT 1 | 3.821 | 5.079 |
| Net income 1 | 3.947 | 4.179 |
| Net Debt 1 | -30.75 | -15.75 |
| Reference price 2 | 40.24 | 35.00 |
| Nbr of stocks (in thousands) | 2,282 | 2,282 |
| Announcement Date | 26/8/25 | 22/8/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 754K | ||
| 12.77x | 0.39x | 8.22x | 3.03% | 112B | ||
| 15.03x | 1.86x | 9.3x | 0.7% | 96.35B | ||
| -276.43x | 18.99x | -322.89x | -.--% | 56.33B | ||
| 12.69x | 1.42x | 8.57x | 2.81% | 26.23B | ||
| 22.55x | 2.08x | 11.9x | 0.93% | 25.48B | ||
| 22.7x | 2.54x | 12.88x | 1.43% | 25.48B | ||
| 31.28x | 5.67x | 23.55x | 2.23% | 21.32B | ||
| 7.91x | 1.43x | 6.48x | -.--% | 20.98B | ||
| 20.94x | 1.86x | 9.37x | 3.33% | 19.83B | ||
| Average | -14.50x | 4.03x | -25.85x | 1.61% | 40.43B | |
| Weighted average by Cap. | -24.62x | 4.05x | -36.33x | 1.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
















